1. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment
   Zhou Lan et al, 2024, Molecular Oncology CrossRef
2. Research progress of MUC1 in genitourinary cancers
   Weipu Mao et al, 2024, Cellular & Molecular Biology Letters CrossRef
3. The role of mucins in gastrointestinal barrier function during health and disease
   Tom Breugelmans et al, 2022, The Lancet Gastroenterology & Hepatology CrossRef
4. Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer
   Kenji Nakahama et al, 2023, Cancer Chemotherapy and Pharmacology CrossRef
5. Poly(I:C)/c-GAMP/Alum ternary adjuvant system synergistically enhances the immunogenicity of glycopeptide antigen
   Shi-Hao Zhou et al, 2023, Journal of Carbohydrate Chemistry CrossRef
6. Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
   Paul Stockhammer et al, 2023, Lung Cancer CrossRef
7. Mesenchymal Stem Cells Ameliorate DSS-Induced Experimental Colitis by Modulating the Gut Microbiota and MUC-1 Pathway
   Han Wang et al, 2023, Journal of Inflammation Research CrossRef
8. The Effectiveness of Traditional Chinese Medicine in Treating Malignancies via Regulatory Cell Death Pathways and the Tumor Immune Microenvironment: A Review of Recent Advances
   Jingya Fu et al, 2024, The American Journal of Chinese Medicine CrossRef
9. The Role of MUC1 in Renal Cell Carcinoma
   Martina Milella et al, 2024, Biomolecules CrossRef
10. Diphtheria Toxoid-Derived T-Helper Epitope and α-galactosylceramide Synergistically Enhance the Immunogenicity of Glycopeptide Antigen
    Jing-Jing Du et al, 2024, ACS Pharmacology & Translational Science CrossRef
11. Conserved signaling modules regulate filamentous growth in fungi: a model for eukaryotic cell differentiation
    Matthew D Vandermeulen et al, 2024, GENETICS CrossRef
12. Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules
    Huifeng Zhang et al, 2023, Pharmaceutics CrossRef
13. Mucins as Potential Biomarkers for Early Detection of Cancer
    Shailendra K. Gautam et al, 2023, Cancers CrossRef
14. Multi‐Targeting Nano‐Systems Targeting Heterogeneous Cancer Cells for Therapeutics and Biomarker Detection
    Xiao‐He Ren et al, 2023, Advanced Healthcare Materials CrossRef
15. The research status and prospects of MUC1 in immunology
    Linna Long et al, 2023, Human Vaccines & Immunotherapeutics CrossRef
16. Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development
    Iwona Radziejewska, 2023, Cancers CrossRef
17. An electrochemical method based on CRISPR-Cas12a and enzymatic reaction for the highly sensitive detection of tumor marker MUC1 mucin
    Zhenhuan Jin et al, 2024, The Analyst CrossRef
18. Aptamer-mediated nano-therapy for pancreatic cancer
    Seyyed Mobin Rahimnia et al, 2024, Recent Advances in Nanocarriers for Pancreatic Cancer Therapy CrossRef
19. A magnetic DNAzyme walker for both in-situ imaging and sensitive detection of MUC1 on living cells
    Ailing Kan et al, 2023, Talanta CrossRef
20. Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
    Kuei-Yen Tsai et al, 2023, Journal of Translational Medicine CrossRef
21. Single extracellular vesicle surface protein‐based blood assay identifies potential biomarkers for detection and screening of five cancers
    Yuxin Min et al, 2024, Molecular Oncology CrossRef
22. Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1
    Putri Cahaya Situmorang et al, 2024, Frontiers in Pharmacology CrossRef
23. Attention-guided variational graph autoencoders reveal heterogeneity in spatial transcriptomics
    Lixin Lei et al, 2024, Briefings in Bioinformatics CrossRef
24. A Multiple Targeting Genome Editing System for Remodulation of Circulating Malignant Cells to Eliminate Cancer Immunosuppression and Restore Immune Responses
    Xiao‐He Ren et al, 2024, Advanced Healthcare Materials CrossRef
25. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer
    Runyu Zhao et al, 2024, Aging CrossRef
26. Prognostic impact of MUC1 and potential regulatory miR-145 and miR-21 expression in salivary mucoepidermoid carcinoma
    Ali Abdolrahmani et al, 2022, Head and Neck Pathology CrossRef
27. Mucin 1 expression is regulated by hsa_circ_0055054/microRNA‑122‑5p and promotes hepatocellular carcinoma development
    Pengfei Hao et al, 2024, Oncology Letters CrossRef
28. Altered glycosylation in cancer: molecular functions and therapeutic potential
    Xuemeng Xu et al, 2024, Cancer Communications CrossRef
29. Epigallocatechin-3-Gallate Prevents the Acquisition of a Cancer Stem Cell Phenotype in Ovarian Cancer Tumorspheres through the Inhibition of Src/JAK/STAT3 Signaling
    Sahily Rodriguez Torres et al, 2023, Biomedicines CrossRef
30. Anti-cancer effects of pyrazole-platinum(II) complexes combined with anti-MUC1 monoclonal antibody versus monotherapy in DLD-1 and HT-29 colon cancer cells
    Katarzyna Supruniuk et al, 2022, Translational Oncology CrossRef